Pediatric nonalcoholic fatty liver disease

Nutrition in Clinical Practice

Volumn 28, Issue 4, 2013, Pages 448-458

  Bozic, Molly A ^a   Subbarao, Girish ^a   Molleston, Jean P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

liver diseases; non alcoholic fatty liver disease; obesity fatty liver; pediatrics

Indexed keywords

ALPHA TOCOPHEROL; MERCAPTAMINE; METFORMIN; PROBIOTIC AGENT; URSODEOXYCHOLIC ACID;

AEROBIC EXERCISE; BARIATRIC SURGERY; CHILDHOOD DISEASE; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; DIETARY INTAKE; DISEASE COURSE; DRUG MEGADOSE; DYSLIPIDEMIA; ECHOGRAPHY; ETHNICITY; FATTY LIVER; GOLD STANDARD; HEPATOGRAPHY; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LABORATORY TEST; LIFESTYLE MODIFICATION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MEDICAL HISTORY; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PREVALENCE; RACE; REVIEW; SCREENING TEST; WEIGHT REDUCTION;

EID: 84881342306     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533613489153     Document Type: Review

References (87)

1. Molleston J, White F, Teckman J, Fitzgerald JF. Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol. 2002 ; 97 (9). 2460-2462
2. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980 ; 55 (7). 434-438
3. Moran JR, Ghishan FK, Halter SA, Greene HL. Steatohepatitis in obese children: a cause of chronic liver dysfunction. Am J Gastroenterol. 1983 ; 78 (6). 374-377
4. Franzese A, Vajro P, Argenziano A, et al. Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci. 1997 ; 42 (7). 1428-1432
5. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr. 1984 ; 3 (3). 408-414
6. Manton ND, Lipsett J, Moore DJ, Davidson GP, Bourne AJ, Couper RTL. Non-alcoholic steatohepatitis in children and adolescents. Med J Aust. 2000 ; 173 (9). 476-479
7. Brunt EM. Pathology of nonalcoholic steatohepatitis. Hepatol Res. 2005 ; 33 (2). 68-71
8. Day CP, James OFW. Steatohepatitis: a tale of two "hits"?. Gastroenterology. 1998 ; 114 (4). 842-845
9. Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in nonalcoholic fatty liver disease. Semin. Liver Dis. 2008 ; 28 (4). 370-379
10. Smith BW, Adams LA. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol. 2011 ; 7 (8). 456-465
11. Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2004 ; 99 (8). 1497-1502
12. MacDonald GA, Bridle KR, Ward PJ, et al. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J Gastroenterol Hepatol. 2001 ; 16 (6). 599-606
13. Robertson G, Leclercq I, Farrell GC. Nonalcoholic steatosis and steatohepatitis, II: cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol. 2001 ; 281 (5). G1135 - G1139
14. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001 ; 120 (5). 1183-1192
15. James O, Day C. Non-alcoholic steatohepatitis: another disease of affluence. Lancet. 1999 ; 353 (9165). 1634-1636
16. Kelley GL, Allan G, Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology. 2004 ; 145 (2). 548-555
17. Lee L, Alloosh M, Saxena R, et al. Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine. Hepatology. 2009 ; 50 (1). 56-67
18. Damaso AR, do Prado WL, de Piano A, et al. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents. Dig Liver Dis. 2008 ; 40 (2). 132-139
19. Petta S, Amato MC, Di Marco V, et al. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2012 ; 35 (2). 238-247
20. Mirza MS. Obesity, visceral fat, and NAFLD: querying the role of adipokines in the progression of nonalcoholic fatty liver disease. ISRN Gastroenterol. 2011 ; 2011: 592404
21. Quiros-Tejeira RE, Rivera CA, Ziba TT, Mehta N, Smith CW, Butte NF. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or =95th percentile. J Pediatr Gastroenterol Nutr. 2007 ; 44 (2). 228-236
22. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006 ; 118 (4). 1388-1393
23. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics. 2005 ; 115 (5). e561 - e565
24. Dwyer JT, Stone EJ, Yang M, et al. Prevalence of marked overweight and obesity in a multiethnic pediatric population: findings from the child and adolescent trial for cardiovascular health (CATCH) study. J Am Diet Assoc. 2000 ; 100 (10). 1149-1156
25. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012 ; 55 (6). 2005-2023
26. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990 ; 12 (5). 1106-1110
27. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr. 2000 ; 136 (6). 727-733
28. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006 ; 295 (13). 1549-1555
29. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010 ; 303 (3). 242-249
30. Muntner P, He J, Cutler JA, Wildman RP, Whelton PK. Trends in blood pressure among children and adolescents. JAMA. 2004 ; 291 (17). 2107-2113
31. Williams DE, Cadwell BL, Cheng YJ, et al. Prevalence of impaired fasting glucose and its relationship with cardiovascular disease risk factors in US adolescents, 1999-2000. Pediatrics. 2005 ; 116 (5). 1122-1126
32. Carter-Kent C, Yerian LM, Brunt EM, et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology. 2009 ; 50 (4). 1113-1120
33. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003 ; 143 (4). 500-505
34. Kistler KD, Molleston J, Unalp A, Abrams SH, Behling C, Schwimmer JB. Symptoms and quality of life in obese children and adolescents with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2010 ; 31 (3). 396-406
35. Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005 ; 129 (1). 113-121
36. Musso G, Gambino R, Cassader M, Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011 ; 43 (8). 617-649
37. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011 ; 34 (3). 274-285
38. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009 ; 58 (11). 1538-1544
39. Kohli R, Boyd T, Lake K, et al. Rapid progression of NASH in childhood. J Pediatr Gastroenterol Nutr. 2010 ; 50 (4). 453-456
40. Manco M, Bedogni G, Marcellini M, et al. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut. 2008 ; 57 (9). 1283-1287
41. Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000 ; 30 (1). 48
42. Fishbein M, Castro F, Cheruku S, et al. Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol. 2005 ; 39 (7). 619-625
43. Sartorio A, Del Col A, Agosti F, et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr. 2006 ; 61 (7). 877-883
44. Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation. 2008 ; 118 (3). 277-283
45. Patton HM, Yates K, Unalp-Arida A, et al. Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease. Am J Gastroenterol. 2010 ; 105 (9). 2093-2102
46. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med. 2010 ; 363 (14). 1341-1350
47. Targher G, Bertolini L, Padovani R, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care. 2006 ; 29 (6). 1325-1330
48. Lavine JE, Yates K, Brunt EM, et al. The natural history of nonalcoholic fatty liver disease in children and adolescents assessed in placebo recipients in the TONIC trial. ; Paper presented at: American Association for the Study of Liver Diseases Boston, MA ;..
49. Pardee PE, Dunn W, Schwimmer JB. Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Aliment Pharmacol Ther. 2012 ; 35 (2). 248-254
50. Daltro C, Cotrim HP, Alves E, et al. Nonalcoholic fatty liver disease associated with obstructive sleep apnea: just a coincidence?. Obes Surg. 2010 ; 20 (11). 1536-1543
51. Norman D, Bardwell WA, Arosemena F, et al. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep. 2008 ; 31 (1). 121-126
52. Singh H, Pollock R, Uhanova J, Kryger M, Hawkins K, Minuk GY. Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease. Dig Dis Sci. 2005 ; 50 (12). 2338-2343
53. Schwimmer JB, Dunn W, Norman GJ, et al. SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology. 2010 ; 138 (4). 1357-1364
54. Uslusoy HS, Nak SG, Gulten M, Biyikli Z. Non-alcoholic steatohepatitis with normal aminotransferase values. World J Gastroenterol. 2009 ; 15 (15). 1863-1868
55. Fracanzani AL, Valenti L, Bugianesi E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008 ; 48 (3). 792-798
56. Patton HM, Lavine JE, Van Natta ML, Schwimmer JB, Kleiner D, Molleston J. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology. 2008 ; 135 (6). 1961-1971
57. Molleston J, Schwimmer JB, Murray KF, Cummings OW, Scheimann AO, Unalp A. Spectrum of histological changes in pediatric nonalcoholic fatty liver disease with normal ALT. Paper presented at: North American Society for Pediatric Gastroenterology, Hepatology and Nutrition; San Diego; NASPGHAN ; ;..
58. Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver Dis. 2007 ; 11 (1). 37-54
59. Hepburn MJ, Vos JA, Fillman EP, Lawitz EJ. The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study. BMC Gastroenterol. 2005 ; 5: 14
60. Siegelman ES, Rosen MA. Imaging of hepatic steatosis. Semin Liver Dis. 2001 ; 21 (1). 71-80
61. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003 ; 29 (12). 1705-1713
62. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005 ; 41 (6). 1313-1321
63. Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005 ; 42 (3). 641-649
64. Barlow SE. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007 ; 120: S164 - S192
65. Devadason CA, Scheimann AO. Overview of screening methods for fatty liver disease in children. World J Hepatol. 2012 ; 4 (1). 1-4
66. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2009 ; 50 (4). 1282-1293
67. Nobili V, Marcellini M, Devito R, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology. 2006 ; 44 (2). 458-465
68. Nobili V, Manco M, Devito R, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology. 2008 ; 48 (1). 119-128
69. Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008 ; 48 (6). 993-999
70. Vos MB, Weber MB, Welsh J, et al. Fructose and oxidized low-density lipoprotein in pediatric nonalcoholic fatty liver disease: a pilot study. Arch Pediatr Adolesc Med. 2009 ; 163 (7). 674-675
71. Ryan MC, Abbasi F, Lamendola C, Carter S, McLaughlin TL. Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults. Diabetes Care. 2007 ; 30 (5). 1075-1080
72. Andersen RE, Crespo CJ, Bartlett SJ, Cheskin LJ, Pratt M. Relationship of physical activity and television watching with body weight and level of fatness among children: results from the third national health and nutrition examination survey. JAMA. 1998 ; 279 (12). 938-942
73. Gortmaker SL, Must A, Sobol AM, Peterson K, Colditz GA, Dietz WH. Television viewing as a cause of increasing obesity among children in the United States, 1986-1990. Arch Pediatr Adolesc Med. 1996 ; 150 (4). 356-362
74. Pardee PE, Norman GJ, Lustig RH, Preud'homme D, Schwimmer JB. Television viewing and hypertension in obese children. Am J Prev Med. 2007 ; 33 (6). 439-443
75. Children, adolescents, and television. Pediatrics. 2001 ; 107 (2). 423-426
76. Understanding Childhood Obesity. Dallas, TX: American Heart Association ; 2011 :
77. Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol. 2011 ; 106 (3). 460-468
78. Washington, DC: U.S. Department of Health and Human Services ; 2008 :
79. Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010 ; 362 (18). 1675-1685
80. Lavine JE, Schwimmer JB, Van Natta ML, et al. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents. JAMA. 2011 ; 305 (16). 1659-1668
81. Ratziu V, de Ledinghen V, Oberti F, et al. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis. J Hepatol. 2011 ; 54 (5). 1011-1019
82. Lindor KD, Kowdley KV, Heathcote EJ, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology. 2004 ; 39 (3). 770-778
83. Cope K, Risby T, Diehl AM. Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology. 2000 ; 119 (5). 1340-1347
84. Lirussi F, Mastropasqua E, Orando S, Orlando R. Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev. 2007 ; (1). CD005165
85. Dohil R, Schmeltzer S, Cabrera BL, et al. Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011 ; 33 (9). 1036-1044
86. Klein S, Mittendorfer B, Eagon JC, et al. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology. 2006 ; 130 (6). 1564-1572
87. Mattar SG, Velcu LM, Rabinovitz M, et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg. 2005 ; 242 (4). 610-617